Therapeutic Potential of Trilobatin in Cisplatin-Induced Kidney Injury: Targeting Ferroptosis and Inflammation
Cisplatin-induced acute kidney injury (CI-AKI) is a common and severe complication in cancer patients undergoing chemotherapy, which can progress to chronic kidney disease (CKD) and end-stage renal disease (ESRD). Ferroptosis and inflammation are critical pathological mechanisms underlying CI-AKI. Trilobatin (TLB),...